Agilent, SomaLogic team up on Dx technology

Med tech giant Agilent ($A) has signed a deal with SomaLogic to expand access to that company's protein biomarker discovery platform. Neither side is disclosing financial terms, but the agreement will task Agilent with placing SomaLogic's cutting-edge proteomic assay technology in labs around the world. More

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.